India is building a wider safety net for transplant medicines with a dedicated Biovigilance Programme to strengthen adverse-event monitoring and patient safety.
Congo's Ebola vaccination drive is testing how quickly pharma can turn vaccine research into real-world outbreak protection.
September has emerged as the worst month for dengue in Delhi this year, with the Municipal Corporation of Delhi reporting 121 cases so far.
India’s proposed easier drug rules could help pharma companies shorten development timelines, accelerate generic launches, and improve access to affordable medicines.
India’s race to eliminate cervical cancer gains momentum as HPV vaccination crosses 80 lakh doses, strengthening the country’s prevention efforts.
Centre’s HPV drive comes under watch as a PIL seeks Supreme Court intervention over consent, safety, and accountability.
As swine flu cases climb, Uttar Pradesh moves to make government hospital testing free and strengthens surveillance across the state.
Swine flu concerns are spreading from Delhi to Agra as Uttar Pradesh steps up surveillance, screening and hospital preparedness to track H1N1 cases.
This article explores how counterfeiters are exploiting gaps in healthcare packaging and supply chains. It examines why traditional safeguards are no longer enough and how digital authentication, track-and-trace systems and smarter packaging could he
ICMR researchers reveal a clear mortality risk linked to drug-resistant infections in a major new study. The findings show these infections raise death rates, treatment costs, and hospital stays across Indian tertiary hospitals
.jpg)
, CDSCO.jpg)
